Nigel McCracken

Chief Tech/Sci/R&D Officer presso BERGENBIO ASA

Health Technology

Consumer Services

Finance

Profilo

Nigel McCracken is currently the Chief Scientific Officer at BerGenBio ASA and the Chief Operating Officer at Virax Biolabs Group Ltd.
He previously worked as the Executive Director & VP-Translational Medicine at Debiopharm International SA from 2014 to 2019.
He also held a position as COO and Senior VP-Discovery & Early Development at NuCana Plc.
Dr. McCracken received his undergraduate degree from the University of Strathclyde and his graduate degree from King's College London.

Posizioni attive di Nigel McCracken

Società	Posizione	Inizio
BERGENBIO ASA	Chief Tech/Sci/R&D Officer	01/01/2021
VIRAX BIOLABS GROUP LIMITED	Chief Operating Officer	01/09/2023

Tutte le posizioni attive di Nigel McCracken

Precedenti posizioni note di Nigel McCracken

Società	Posizione	Fine
Debiopharm International SA Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland.	Director/Board Member	01/04/2019
NUCANA PLC	Chief Operating Officer	-

Vedi nel dettaglio l'esperienza di Nigel McCracken

Formazione di Nigel McCracken

University of Strathclyde	Undergraduate Degree
King's College London	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Nigel McCracken

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	3
BERGENBIO ASA	Health Technology
NUCANA PLC	Health Technology
VIRAX BIOLABS GROUP LIMITED	Finance

Aziende private	1
Debiopharm International SA Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland.	Health Technology